日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

IGFBP4 is a Metric for Primary Biliary Cholangitis and Attenuates Biliary Epithelial Cell Injury

IGFBP4是原发性胆汁性胆管炎的指标,并能减轻胆管上皮细胞损伤。

Zhou, Xing; Shao, Shuyu; Yang, Danning; Cheng, Ziyan; Tanaka, Toshihiro; Leung, Patrick S C; Tsuneyama, Koichi; Ansari, Aftab A; Ridgway, William M; Invernizzi, Pietro; Bowlus, Christopher L; Gershwin, M Eric; Zhang, Weici

The Treatment of Primary Biliary Cholangitis: Time for Personalized Medicine

原发性胆汁性胆管炎的治疗:是时候进行个体化治疗了

Men, Xinyi; Liu, Yansheng; Zhao, Han; Xie, Bingrui; Guo, Changcun; Leung, Patrick S C; Timilsina, Suraj; Gershwin, M Eric; Shang, Yulong; Han, Ying

Tryptophan catabolites from microbiota ameliorate immune-mediated hepatitis through activating aryl hydrocarbon receptor of T cells

肠道菌群产生的色氨酸代谢产物通过激活T细胞的芳烃受体来改善免疫介导的肝炎。

Li, Bo; Liang, Xueying; Li, Yikang; Wang, Rui; Wei, Yiran; Liu, Qiaoyan; Zhang, Jun; Wang, Qixia; Miao, Qi; Xiao, Xiao; Lian, Min; Wang, Zhi; Zhou, Yufeng; Gershwin, M Eric; You, Zhengrui; Tang, Ruqi; Ma, Xiong

Recompensation in patients with autoimmune hepatitis-related decompensated cirrhosis following immunosuppressive therapy

免疫抑制治疗后自身免疫性肝炎相关失代偿性肝硬化患者的再代偿

Chen, Yu; Wen, Haoyu; Li, You; Zhang, Weituo; Mao, Tianyu; Jiang, Chenyi; Zhang, Huayang; Zhou, Yujie; Pu, Xiting; Li, Bo; Zhang, Jun; Yan, Li; Lian, Min; Sheng, Li; Guo, Canjie; Wang, Qixia; Miao, Qi; Hua, Jing; Li, Hai; Tang, Ruqi; Bowlus, Christopher L; Gershwin, M Eric; You, Zhengrui; Xiao, Xiao; Ma, Xiong

Fine mapping identifies independent HLA associations in autoimmune hepatitis type 1

精细定位鉴定出自身免疫性肝炎1型中的独立HLA关联

Li, You; Zhou, Lu; Huang, Zuxiong; Yang, Yue; Zhang, Jiming; Yang, Ling; Xu, Yun; Shi, Junping; Tang, Shanhong; Yuan, Xiaoling; Xu, Jie; Li, Yiling; Han, Xu; Li, Jia; Liu, Yanmin; Sun, Ying; Jin, Xiaozhi; Xiao, Xiao; Wang, Bangmao; Lin, Qiuxiang; Zhou, Yang; Song, Xuejiao; Cui, Yong; Hu, Lilin; Song, Yuhu; Bao, Jie; Gong, Ling; Gershwin, M Eric; Zuo, Xianbo; Yan, Huiping; Zou, Zhengsheng; Tang, Ruqi; Ma, Xiong

Dietary therapy of murine primary biliary cholangitis induces hepatocellular steatosis: A cautionary tale

饮食疗法治疗小鼠原发性胆汁性胆管炎可诱发肝细胞脂肪变性:一个警示故事

Zhang, Weici; Al Tekreeti, Taha; Leung, Patrick S C; Tsuneyama, Koichi; Dhillon, Harleen; Rojas, Manuel; Heuer, Luke S; Ridgway, William M; Ansari, Aftab A; Young, Howard A; Mackay, Charles R; Gershwin, M Eric

Autoantibodes to GP210 are a metric for UDCA responses in primary biliary cholangitis

针对 GP210 的自身抗体是原发性胆汁性胆管炎中 UDCA 疗效的指标。

Wang, Chan; Qin, Zhuye; Zhang, Mingming; Dai, Yaping; Zhang, Luyao; Tian, Wenyan; Gong, Yuhua; Chen, Sufang; Yang, Can; Xu, Ping; Shi, Xingjuan; Zhao, Weifeng; Timilsina, Suraj; Gershwin, M Eric; Chen, Weichang; Qiu, Fang; Liu, Xiangdong

Molecular mimicry and autoimmunity in the time of COVID-19

新冠疫情时期的分子模拟和自身免疫

Rojas, Manuel; Herrán, María; Ramírez-Santana, Carolina; Leung, Patrick S C; Anaya, Juan-Manuel; Ridgway, William M; Gershwin, M Eric

Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion

预测和评估接受熊去氧胆酸治疗的原发性胆汁性胆管炎高危患者:早期标准

Yang, Chunmei; Guo, Guanya; Li, Bo; Zheng, Linhua; Sun, Ruiqing; Wang, Xiufang; Deng, Juan; Jia, Gui; Zhou, Xia; Cui, Lina; Guo, Changcun; Zhou, Xinmin; Leung, Patrick S C; Gershwin, M Eric; Shang, Yulong; Han, Ying

PPAR agonists for the treatment of primary biliary cholangitis: Old and new tales

PPAR激动剂治疗原发性胆汁性胆管炎:新旧进展

Colapietro, Francesca; Gershwin, M Eric; Lleo, Ana